New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
- 25 November 2002
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 21 (54), 8293-8301
- https://doi.org/10.1038/sj.onc.1206118
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 22 references indexed in Scilit:
- Genetics of hepatocellular carcinomaSeminars in Cancer Biology, 2000
- AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1Nature Genetics, 2000
- Activation of β-catenin in epithelial and mesenchymal hepatoblastomasOncogene, 2000
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999
- Liver-Directed Gene Transfer VectorsHuman Gene Therapy, 1998
- The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in miceOncogene, 1998
- Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomasProceedings of the National Academy of Sciences, 1998
- Glutamine synthetase and hepatocarcinogenesisCarcinogenesis: Integrative Cancer Research, 1995
- Overexpression of glutamine synthetase in human primary liver cancerGastroenterology, 1994
- Evidence that interaction of hepatocytes with the collecting (hepatic) veins triggers position-specific transcription of the glutamine synthetase and ornithine aminotransferase genes in the mouse liver.Molecular and Cellular Biology, 1991